JP2016512250A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512250A5 JP2016512250A5 JP2016500489A JP2016500489A JP2016512250A5 JP 2016512250 A5 JP2016512250 A5 JP 2016512250A5 JP 2016500489 A JP2016500489 A JP 2016500489A JP 2016500489 A JP2016500489 A JP 2016500489A JP 2016512250 A5 JP2016512250 A5 JP 2016512250A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- hours
- particles
- particle size
- sulfonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/832,694 US20140271892A1 (en) | 2013-03-15 | 2013-03-15 | Phenylephrine resinate particles having good auc |
| US13/832,694 | 2013-03-15 | ||
| PCT/US2014/019301 WO2014149526A1 (en) | 2013-03-15 | 2014-02-28 | Phenylephrine resinate particles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512250A JP2016512250A (ja) | 2016-04-25 |
| JP2016512250A5 true JP2016512250A5 (https=) | 2017-03-09 |
| JP6314206B2 JP6314206B2 (ja) | 2018-04-18 |
Family
ID=50272778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500489A Expired - Fee Related JP6314206B2 (ja) | 2013-03-15 | 2014-02-28 | 樹脂酸フェニレフリン粒子 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20140271892A1 (https=) |
| EP (1) | EP2968223B1 (https=) |
| JP (1) | JP6314206B2 (https=) |
| CN (2) | CN105263483A (https=) |
| AU (1) | AU2014238059B2 (https=) |
| BR (1) | BR112015022975B1 (https=) |
| CA (1) | CA2906357C (https=) |
| IL (1) | IL241050B (https=) |
| MX (1) | MX383890B (https=) |
| PH (1) | PH12015502066A1 (https=) |
| RU (1) | RU2675788C2 (https=) |
| UA (1) | UA116372C2 (https=) |
| WO (1) | WO2014149526A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41152A (fr) * | 2014-12-12 | 2017-10-17 | Johnson & Johnson Consumer Inc | Procédé de fabrication de particules de résinate de phényléphrine ; particules de résinate de phényléphrine et utilisation des particules de résinate de phényléphrine dans des formulations pharmaceutiques |
| CN109187832B (zh) * | 2018-09-30 | 2021-07-30 | 华润三九医药股份有限公司 | Lc-ms/ms测定去氧肾上腺素浓度的方法及样品的前处理方法 |
| MX2023007741A (es) * | 2020-12-29 | 2023-09-15 | Abbvie Inc | Formulaciones de upadacitinib de liberacion prolongada. |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH693625A5 (it) * | 1999-02-18 | 2003-11-28 | Inpharma Sa | Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi. |
| US20030099711A1 (en) * | 2001-08-29 | 2003-05-29 | David Meadows | Sustained release preparations |
| US20040265373A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| US9492541B2 (en) * | 2004-09-14 | 2016-11-15 | Sovereign Pharmaceuticals, Llc | Phenylepherine containing dosage form |
| US20050266032A1 (en) * | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
| US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
| CN102488652B (zh) * | 2006-03-16 | 2014-06-18 | 特瑞斯制药股份有限公司 | 含有药物-离子交换树脂复合物的经修饰释放的制剂 |
| US20080064694A1 (en) * | 2006-09-11 | 2008-03-13 | Auriga Laboratories, Inc. | Multi-Phase Release Methscopolamine Compositions |
| JP2010510320A (ja) * | 2006-11-21 | 2010-04-02 | マクニール−ピーピーシー・インコーポレーテツド | 改変型放出鎮痛性懸濁液 |
| US8323695B2 (en) * | 2007-08-13 | 2012-12-04 | Mcneil-Ppc, Inc. | Method for stabilizing phenylephrine |
| RU2011102777A (ru) * | 2008-06-26 | 2012-08-10 | МакНЕЙЛ-ППС, ИНК. (US) | Частицы с покрытием, содержащие фармацевтически активные агенты |
| WO2010115015A1 (en) * | 2009-04-03 | 2010-10-07 | Coating Place, Inc. | Modified-release pharmaceutical drug composition |
| US20130230587A1 (en) * | 2010-11-10 | 2013-09-05 | Rubicon Research Private Limited | Sustained release compositions |
-
2013
- 2013-03-15 US US13/832,694 patent/US20140271892A1/en not_active Abandoned
-
2014
- 2014-02-28 CN CN201480015698.2A patent/CN105263483A/zh active Pending
- 2014-02-28 MX MX2015012340A patent/MX383890B/es unknown
- 2014-02-28 CN CN202010471359.2A patent/CN111658624A/zh active Pending
- 2014-02-28 UA UAA201509684A patent/UA116372C2/uk unknown
- 2014-02-28 EP EP14709863.6A patent/EP2968223B1/en active Active
- 2014-02-28 CA CA2906357A patent/CA2906357C/en active Active
- 2014-02-28 AU AU2014238059A patent/AU2014238059B2/en not_active Ceased
- 2014-02-28 BR BR112015022975-1A patent/BR112015022975B1/pt not_active IP Right Cessation
- 2014-02-28 RU RU2015144181A patent/RU2675788C2/ru active
- 2014-02-28 JP JP2016500489A patent/JP6314206B2/ja not_active Expired - Fee Related
- 2014-02-28 WO PCT/US2014/019301 patent/WO2014149526A1/en not_active Ceased
-
2015
- 2015-09-02 IL IL241050A patent/IL241050B/en active IP Right Grant
- 2015-09-11 PH PH12015502066A patent/PH12015502066A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7019727B2 (ja) | インフルエンザの治療方法 | |
| Li et al. | Silver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathways | |
| Wang et al. | Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase | |
| JP2012503668A5 (https=) | ||
| JP2014528474A5 (https=) | ||
| JP2016512250A5 (https=) | ||
| JP2016518388A5 (https=) | ||
| JP2010515682A5 (https=) | ||
| Wu et al. | ZIF‐67‐Derived Antivirus Cobalt Hydroxide LDH Nanosheets Produced through High‐Concentration Cobalt Ion‐Assisted Hydration | |
| BRPI0906851B1 (pt) | Formulação em aerossol com sais de aminoácidos básicos de ácido acetilsalicílico e uso de sais de aminoácidos básicos de ácido acetilsalicílico no tratamento de infecções virais | |
| JP2015515968A5 (https=) | ||
| CN104288170B (zh) | 松果菊苷在抗肿瘤药物中的应用 | |
| Lu et al. | Physicochemical and pharmacokinetic evaluation of spray-dried coformulation of Salvia miltiorrhiza polyphenolic acid and L-leucine with improved bioavailability | |
| Mokra et al. | N-acetylcysteine in the treatment of acute lung injury: perspectives and limitations | |
| RU2015144181A (ru) | Частицы резината фенилэфрина | |
| JP2020125344A (ja) | 樹脂酸フェニレフリン粒子の製造プロセス | |
| MX373699B (es) | Composicion farmaceutica que contiene budesonida y formoterol. | |
| CN104800183A (zh) | 一种阿司匹林肠溶片及其制备方法和应用 | |
| CN103705537A (zh) | 硫化氢及其供体硫氢化钠在制备治疗脂质代谢紊乱药物中的用途 | |
| CN101502495A (zh) | 吡嘧司特钾片及其生产工艺 | |
| CN103341026B (zh) | 一种防治流感的组合物及其制剂制备方法和应用 | |
| CN104739761A (zh) | 一种盐酸氨溴索毫微粒的制备方法 | |
| WO2018201920A1 (zh) | 龙虎人丹在制备预防和/或治疗肝纤维化药物中的应用 | |
| CN102416014A (zh) | 一种生物碱类成分组合物在制备抗甲型h1n1流感病毒药物中的应用 | |
| CN111655252A (zh) | 含有亚铁氨基酸粒子的组合物及其用于制造治疗或改善胰脏相关疾病的医药品的用途 |